CN104474281A - 治疗甲状腺癌的中药配方 - Google Patents
治疗甲状腺癌的中药配方 Download PDFInfo
- Publication number
- CN104474281A CN104474281A CN201410756960.0A CN201410756960A CN104474281A CN 104474281 A CN104474281 A CN 104474281A CN 201410756960 A CN201410756960 A CN 201410756960A CN 104474281 A CN104474281 A CN 104474281A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- traditional chinese
- thyroid cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 29
- 201000002510 thyroid cancer Diseases 0.000 title claims abstract description 20
- 239000009636 Huang Qi Substances 0.000 claims abstract description 9
- 241000756943 Codonopsis Species 0.000 claims abstract description 8
- 241000131808 Scolopendra Species 0.000 claims abstract description 7
- 210000000582 Semen Anatomy 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 6
- 201000005161 thyroid carcinoma Diseases 0.000 claims description 15
- 241001250596 Pleione Species 0.000 claims description 7
- 240000000218 Cannabis sativa Species 0.000 claims description 6
- 210000004369 Blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 230000000694 effects Effects 0.000 abstract description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 12
- 230000001737 promoting Effects 0.000 abstract description 12
- 230000017531 blood circulation Effects 0.000 abstract description 9
- 230000002522 swelling Effects 0.000 abstract description 7
- 210000004914 menses Anatomy 0.000 abstract description 2
- 230000005906 menstruation Effects 0.000 abstract description 2
- 241000846171 Cremastra Species 0.000 abstract 1
- 235000015506 Solanum lyratum Nutrition 0.000 abstract 1
- 241000585552 Solanum lyratum Species 0.000 abstract 1
- 230000003213 activating Effects 0.000 abstract 1
- 239000009670 cang er zi wan Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000002588 toxic Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 13
- 210000001685 Thyroid Gland Anatomy 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 6
- 231100000614 Poison Toxicity 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004185 Liver Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- HCHKCACWOHOZIP-UHFFFAOYSA-N zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 5
- 239000011701 zinc Substances 0.000 description 5
- 229910052725 zinc Inorganic materials 0.000 description 5
- 210000004072 Lung Anatomy 0.000 description 4
- 210000000214 Mouth Anatomy 0.000 description 4
- 210000000952 Spleen Anatomy 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N Taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 208000009955 Thyroid Neoplasms Diseases 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000003203 everyday Effects 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 201000008827 tuberculosis Diseases 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010017553 Furuncle Diseases 0.000 description 3
- 206010018498 Goitre Diseases 0.000 description 3
- 208000004396 Mastitis Diseases 0.000 description 3
- 206010027476 Metastasis Diseases 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 210000003800 Pharynx Anatomy 0.000 description 3
- 239000003651 drinking water Substances 0.000 description 3
- 235000020188 drinking water Nutrition 0.000 description 3
- 235000005035 ginseng Nutrition 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 201000003872 goiter Diseases 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 230000002175 menstrual Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000001519 tissues Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 210000003414 Extremities Anatomy 0.000 description 2
- 208000006454 Hepatitis Diseases 0.000 description 2
- 210000003734 Kidney Anatomy 0.000 description 2
- 210000001165 Lymph Nodes Anatomy 0.000 description 2
- 208000007054 Medullary Carcinoma Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010028372 Muscular weakness Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 229960003080 Taurine Drugs 0.000 description 2
- 230000001154 acute Effects 0.000 description 2
- 201000000736 amenorrhea Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 201000009030 carcinoma Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 2
- 201000003265 lymphadenitis Diseases 0.000 description 2
- 230000036473 myasthenia Effects 0.000 description 2
- 230000002685 pulmonary Effects 0.000 description 2
- 230000002269 spontaneous Effects 0.000 description 2
- 230000001502 supplementation Effects 0.000 description 2
- 201000010874 syndrome Diseases 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000007502 Anemia Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003246 Arthritis Diseases 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 206010003549 Asthenia Diseases 0.000 description 1
- 208000006673 Asthma Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 210000004204 Blood Vessels Anatomy 0.000 description 1
- 210000001124 Body Fluids Anatomy 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 210000001773 Cervical Plexus Anatomy 0.000 description 1
- 206010008909 Chronic hepatitis Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000004981 Coronary Disease Diseases 0.000 description 1
- 208000000264 Deglutition Disorders Diseases 0.000 description 1
- 206010012601 Diabetes mellitus Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013781 Dry mouth Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013950 Dysphagia Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 206010015037 Epilepsy Diseases 0.000 description 1
- 241001386819 Euchresta japonica Species 0.000 description 1
- 210000000416 Exudates and Transudates Anatomy 0.000 description 1
- 208000003512 Furunculosis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 210000004907 Glands Anatomy 0.000 description 1
- 229940096919 Glycogen Drugs 0.000 description 1
- BYSGBSNPRWKUQH-UJDJLXLFSA-N Glycogen Chemical group O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](O)[C@@H](O[C@@H]2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)O1 BYSGBSNPRWKUQH-UJDJLXLFSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010019233 Headache Diseases 0.000 description 1
- 206010019847 Hepatosplenomegaly Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000010473 Hoarseness Diseases 0.000 description 1
- 201000002309 Horner's syndrome Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 206010022114 Injury Diseases 0.000 description 1
- 206010022437 Insomnia Diseases 0.000 description 1
- 206010067997 Iodine deficiency Diseases 0.000 description 1
- 230000037013 METABOLISM RATE Effects 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 206010061284 Mental disease Diseases 0.000 description 1
- 210000004080 Milk Anatomy 0.000 description 1
- 206010073148 Multiple endocrine neoplasia Type 2A Diseases 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 241001523579 Ostrea Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000592274 Polypodium vulgare Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000008425 Protein Deficiency Diseases 0.000 description 1
- 208000008128 Pulmonary Tuberculosis Diseases 0.000 description 1
- 210000004915 Pus Anatomy 0.000 description 1
- 206010039083 Rhinitis Diseases 0.000 description 1
- 241000208225 Rhus Species 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N Rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229940081967 Rutin Drugs 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 210000002784 Stomach Anatomy 0.000 description 1
- 229960000716 TONICS Drugs 0.000 description 1
- 210000001550 Testis Anatomy 0.000 description 1
- 208000009453 Thyroid Nodule Diseases 0.000 description 1
- 208000004371 Toothache Diseases 0.000 description 1
- 206010052769 Vertigos Diseases 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000001139 anti-pruritic Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004027 cells Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000008739 coronary artery disease Diseases 0.000 description 1
- 230000000994 depressed Effects 0.000 description 1
- 201000004624 dermatitis Diseases 0.000 description 1
- 231100000406 dermatitis Toxicity 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 230000000916 dilatatory Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940079593 drugs Drugs 0.000 description 1
- 101700059225 eat-2 Proteins 0.000 description 1
- 230000001037 epileptic Effects 0.000 description 1
- 201000000297 erysipelas Diseases 0.000 description 1
- 230000001815 facial Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 210000000185 follicular epithelial cell Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019525 fullness Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002757 inflammatory Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 235000006479 iodine deficiency Nutrition 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000002266 menstruation inducing agent Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000116 mitigating Effects 0.000 description 1
- 230000002969 morbid Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000025627 positive regulation of urine volume Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000001105 regulatory Effects 0.000 description 1
- 230000001850 reproductive Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229930002876 rutin Natural products 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 201000004409 schistosomiasis Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000003393 splenic Effects 0.000 description 1
- 230000004936 stimulating Effects 0.000 description 1
- 229920000638 styrene acrylonitrile Polymers 0.000 description 1
- 230000000576 supplementary Effects 0.000 description 1
- 230000000152 swallowing Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002889 sympathetic Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001256 tonic Effects 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/536—Prunella or Brunella (selfheal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
本发明公开了一种治疗甲状腺癌的中药配方,由以下重量份数的中药原料配制而成:蜈蚣12-15份、贝母10-13份、山慈菇12-15份、王不留行12-18份、昆布10-12份、苍耳草8-12份、白英10-13份、山豆根10-12份、丹参12-18份、水红花子14-17份、牡蛎13-16份、夏枯草6-8份、党参8-12份、黄芪6-12份和白芷8-10份,根据中药扶正固本、活血化瘀的理论,化痰与治瘀双管齐下,清热解毒,化痰散结、活血通经、解散消肿,益气养阴,治疗甲状腺癌效果好,见效快。
Description
技术领域
[0001] 本发明属于中医中药技术领域,特别涉及一种治疗甲状腺癌的中药配方。
背景技术
[0002] 甲状腺癌是最常见的甲状腺恶性肿瘤,约占全身恶性肿瘤的1%。除髓样癌外,绝大部分甲状腺癌起源于滤泡上皮细胞。
[0003] 甲状腺内发现肿块,质地硬而固定、表面不平是各型癌的共同表现。腺体在吞咽时上下移动性小。未分化癌可在短期内出现上述症状,除肿块增长明显外,还伴有侵犯周围组织的特性。晚期可产生声音撕哑、呼吸、吞咽困难和交感神经受压引起Horner综合征及侵犯颈丛出现耳、枕、肩等处疼痛和局部淋巴结及远处器官转移等表现。颈淋巴结转移在未分化癌发生较早。有的患者甲状腺肿块不明显,因发现转移灶而就医时,应想到甲状腺癌的可能。髓样癌患者应排除II型多发性内分泌腺瘤综合征的可能。对合并家族史和出现腹泻、颜面潮红、低血钙时应注意。
[0004] 根据临床表现,若甲状腺肿块质硬、固定,颈淋巴结肿大,或有压迫症状者,或存在多年的甲状腺肿块,在短期内迅速增大者,均应怀疑为甲状腺癌。
发明内容
[0005] 本发明提供一种治疗甲状腺癌的中药配方,通过中药调理,扶正固本、活血化瘀的理论,化痰与治瘀双管齐下,清热解毒,化痰散结、活血通经、解散消肿,益气养阴,治疗甲状腺癌效果好,见效快。
[0006] 本发明的治疗甲状腺癌的中药配方,其特征在于由以下重量份数的中药原料配制而成:蜈蚣12-15份、贝母10-13份、山慈菇12-15份、王不留行12-18份、昆布10-12份、苍耳草8-12份、白英10-13份、山豆根10-12份、丹参12-18份、红粉12-15份、水红花子14-17份、牡蝴13-16份、夏枯草6-8份、党参8-12份、黄苗6-12份和白]E 8-10份。
[0007] 作为优选,按如下重量份数配制:蜈蚣15份、贝母12份、山慈菇13份、王不留行15份、昆布11份、苍耳草9份、白英12份、山豆根11份、丹参15份、红粉14份、水红花子15份、牡蛎14份、夏枯草7份、党参10份、黄芪9份和白芷9份。
[0008] 制备方法是按上述重量份数称取原料,放入砂锅里,然后加入饮用水,液面超出药材2-3cm,武火煮开后,改用文火煎煮50分钟后,倒出药液,每次温服200-300ml,每日早、晚两次饭后服用,每14天为一个疗程。
[0009] 药理分析:
[0010] 蜈蚣:为陆生节肢动物,身体由许多体节组成,每一节上均长有步足,故为多足生物。可做中药,有败毒、抗结核、消瘤抗癌作用。
[0011]贝母:性凉,味甘、平。有润肺止咳,化痰平喘,清热化痰功效,具有清热化痰、散结消肿作用。
[0012]山慈菇:清热解毒,化痰散结。用于痈肿疔毒,瘰疬痰核,淋巴结结核,蛇虫咬伤。
[0013] 王不留行:苦,平。归肝、胃经。活血通经,下乳消肿。用于乳汁不下,经闭,痛经,乳痈肿痛。
[0014] 昆布:其作用是由于所含的碘、碘化物引起的。昆布可用来纠正由缺碘而引起的甲状腺机能不足,同时也可以暂时抑制甲状腺机能亢进的新陈代谢率而减轻症状,但不能持久,可作手术前的准备。碘化物进入组织及血液后,尚能促进病理产物如炎症渗出物的吸收。并能使病态的组织崩溃和溶解,故对活动性肺结核一般不用。消痰软坚;利水退肿。主瘰疬;瘿瘤;噎膈;(疒颓)疝脚气水肿。用于瘿瘤,瘰疬,睾丸肿痛,痰饮水肿。
[0015] 苍耳草:味苦;甘;辛;性温;小毒。肺经;肝经。散风寒;通鼻窍;祛风湿;止痒。
[0016]白英,又叫白毛藤,为茄科草质藤本,生于山谷草地或路旁、田边。全草具有清热利湿,解毒消肿,抗癌之功效;根可用于风湿性关节炎。
[0017] 山豆根,拉丁学名(Euchresta japonica),另Ij名:三小叶山豆根、胡豆莲,取其消肿抗癌作用。
[0018] 丹参:根入药,含丹参酮,为强壮性通经剂,有祛瘀、生新、活血、调经等效用,为妇科要药,主治子宫出血,月经不调,血瘀,腹痛,经痛,经闭,庙痛。对治疗冠心病有良好效果。此外亦治神经性衰弱失眠,关节痛,贫血,乳腺炎,淋巴腺炎,关节炎,疮疖痛肿,丹毒,急慢性肝炎,肾孟肾炎,跌打损伤,晚期血吸虫病肝脾肿大,癫癎。外用又可洗漆疮。
[0019] 水红花子:咸,微寒。清热,软坚。用于腹部肿块,颈淋巴结核,糖尿病。功用清热,软坚。消瘀破积,健脾利湿。治胁腹症积,水臌,胃疼,食少腹胀,火眼,疮肿,瘰疬。
[0020] 牡蛎:滋补强壮,牡蛎含18种氨基酸、肝糖元、B族维生素、牛磺酸和钙、磷、铁、锌等营养成分,常吃可以提高机体免疫力。牡蛎所含牛磺酸降血脂、降血压。在古希腊神话里牡蛎是代表爱的食物。从中医角度牡蛎通水气,滋润肺部,利于肾水。西医验证它是含锌最多的天然食品之一(每百克蚝肉含量高达10mg),也就是每天只吃2〜3个牡蛎就提供你全天所需的锌。锌的巨大价值体现在它是男性生殖系统里至关重要的矿物质,尤其是近五十年男性的精子数量下降明显,更需补充足够的锌。
[0021] 夏枯草:夏枯草性寒,味甘、辛、微苦,具有清泄肝火、散结消肿、清热解毒、祛痰止咳、凉血止血的功效,适用于淋巴结核、甲状腺肿、乳痈、头目眩晕、口眼歪斜、筋骨疼痛、肺结核、血崩、带下、急性传染性黄疸型肝炎及细菌性痢疾等。现代药理研宄表明,夏枯草有降低血压的作用,并能扩张血管,其所含芦丁有抗炎作用,并能降低血管通透性,减少脆性,降低肝脂。夏枯草还有抵制癌细胞的作用。
[0022] 党参:味甘,性平。有补中益气、止渴、健脾益肺,养血生津。用于脾肺气虚,食少倦怠,咳嗽虚喘,气血不足,面色萎黄,心悸气短,津伤口渴,内热消渴。懒言短气、四肢无力、食欲不佳、气虚、气津两虚、气血双亏以及血虚萎黄等症。但表证未解而中满邪实的不能用。该品功效与人参相似,惟药力薄弱。治一般虚证,可代替人参使用;虚脱重证,则仍用人参为宜。秋季采挖,洗净,晒干。
[0023] 黄芪:性味:甘,微温;归经:归肺、脾、肝、肾经;主治:表虚自汗,多用于体虚表弱所致的自汗。如表气不固,而汗出,用黄芪配白术、防风治之,久服必效。方如玉屏风散;也可配浮小麦、麻黄根等。
[0024] 白芷:以根入药,有祛病除湿、排脓生肌、活血止痛等功能。主治风寒感冒、头痛、鼻炎、牙痛。赤白带下、痛疖肿毒等症,亦可作香料。
[0025] 甲状腺癌的病因,是痰气结合,需痰瘀同治,本发明的中药配方,根据中医扶正固本、活血化瘀的理论,化痰与治瘀双管齐下,利用夏枯草、水红花子、山慈菇的清热解毒、化痰散结的药性;配伍白芷、山豆根和丹参,活血通经、解散消肿;牡蛎、黄芪、党参,益气养阴,治疗甲状腺癌标本兼治,效果好,见效快。
[0026] 疗效判断:
[0027] 甲状腺癌的主要临床症状有:体质虚弱,四肢无力,甲状腺部CT可见肿瘤。
[0028] 痊愈:体质增强,身上有力,咽喉颈部不适明显缓解,CT显示甲状腺部位肿瘤瘤体缩小,其它部位未发现新生肿瘤。
[0029] 好转:身上无力改善,咽喉颈部不适缓解,CT显示甲状腺部肿瘤瘤体未见增长,其它部位未发现新生肿瘤。
[0030] 无效:诸症无改善,甲状腺部位肿瘤瘤体增大,或其他部位发现新生肿瘤。
[0031] 治疗结果:甲状腺癌患者79例,服用本发明的药物,放入砂锅里,然后加入饮用水,液面超出药材2-3cm,武火煮开后,改用文火煎煮50分钟后,倒出药液,每次温服200-300ml,每日早、晚两次饭后温服,每14天为一个疗程。疫愈64例,占81%,好转15例,占19%,有效率为100%。
[0032] 附几例病例作进一步说明:
[0033] 病例1:季某某,女,山东临沂人,46岁,2012年5月来诊,I个月前自觉情志抑郁、口干、便秘、颈部肿痛、有硬物,生气时肿块增大,检查CT显示甲状腺部肿瘤,入院治疗输液10天无显著效果,肿块逐渐增大。服用本发明的药物,14天后甲状腺结节,质地变软,吞咽顺畅,继续服用14天后,复检,肿瘤直径缩小,继续服药两个疗程后后脖颈逐渐消肿,痊愈。随访一年无复发。
[0034] 病例2:李某,女,39岁,2012年9月自觉颈前有肿块,凹凸不平,去医院检查,确诊为甲状腺癌早期,住院输液I个月无效果转院。2012年11月前来就诊,服用本发明的药物,14天后脖颈肿大症状改善,21天后脖颈逐渐消肿,30天后脖颈消肿痊愈。随访半年无复发。
具体实施方式
[0035] 实施例1
[0036] 蜈蚣15份、贝母12份、山慈菇13份、王不留行15份、昆布11份、苍耳草9份、白英12份、山豆根11份、丹参15份、水红花子15份、牡蛎14份、夏枯草7份、党参10份、黄芪9份和白芷9份。
[0037] 制备方法是按上述重量份数称取原料,放入砂锅里,然后加入饮用水,液面超出药材2-3cm,武火煮开后,改用文火煎煮50分钟后,倒出药液,每次温服200-300ml,每日早、晚两次饭后温服,每14天为一个疗程。
Claims (2)
1.治疗甲状腺癌的中药配方,其特征在于由以下重量份数的中药原料配制而成:蜈蚣12-15份、贝母10-13份、山慈菇12-15份、王不留行12-18份、昆布10-12份、苍耳草8_12份、白英10-13份、山豆根10-12份、丹参12-18份、水红花子14-17份、牡蛎13-16份、夏枯草6-8份、党参8-12份、黄芪6-12份和白芷8_10份。
2.根据权利要求1所述的治疗甲状腺癌的中药配方,其特征在于由以下重量份数的中药原料配制而成:蜈蚣15份、贝母12份、山慈菇13份、王不留行15份、昆布11份、苍耳草9份、白英12份、山豆根11份、丹参15份、水红花子15份、牡蛎14份、夏枯草7份、党参10份、黄芪9份和白芷9份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410756960.0A CN104474281A (zh) | 2014-12-10 | 2014-12-10 | 治疗甲状腺癌的中药配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410756960.0A CN104474281A (zh) | 2014-12-10 | 2014-12-10 | 治疗甲状腺癌的中药配方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104474281A true CN104474281A (zh) | 2015-04-01 |
Family
ID=52748982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410756960.0A Pending CN104474281A (zh) | 2014-12-10 | 2014-12-10 | 治疗甲状腺癌的中药配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104474281A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327205A (zh) * | 2015-12-02 | 2016-02-17 | 青岛市中心医院 | 一种治疗甲状腺癌的中药制剂 |
CN105343741A (zh) * | 2015-12-18 | 2016-02-24 | 赵红 | 一种治疗甲状腺肿瘤的中药及其制备方法 |
CN105521295A (zh) * | 2015-12-28 | 2016-04-27 | 黄维清 | 一种治疗甲状腺肿瘤的中药配方 |
CN105521255A (zh) * | 2015-12-28 | 2016-04-27 | 黄维清 | 一种治疗甲状腺癌的中药配方 |
CN105561200A (zh) * | 2016-02-02 | 2016-05-11 | 耿冲 | 一种治疗甲状腺癌的中药配方及其制备方法 |
CN105749186A (zh) * | 2016-05-05 | 2016-07-13 | 毕恩旭 | 一种治疗甲状腺癌的中药制剂 |
CN105878880A (zh) * | 2016-05-23 | 2016-08-24 | 王激扬 | 一种治疗甲状腺癌的中药及制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520507A (zh) * | 2013-10-25 | 2014-01-22 | 王小薇 | 一种治疗甲状腺癌的中药组合物 |
CN103989906A (zh) * | 2014-05-23 | 2014-08-20 | 吴建阳 | 一种治疗甲状腺癌、淋巴癌的药物组合物 |
-
2014
- 2014-12-10 CN CN201410756960.0A patent/CN104474281A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103520507A (zh) * | 2013-10-25 | 2014-01-22 | 王小薇 | 一种治疗甲状腺癌的中药组合物 |
CN103989906A (zh) * | 2014-05-23 | 2014-08-20 | 吴建阳 | 一种治疗甲状腺癌、淋巴癌的药物组合物 |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105327205A (zh) * | 2015-12-02 | 2016-02-17 | 青岛市中心医院 | 一种治疗甲状腺癌的中药制剂 |
CN105343741A (zh) * | 2015-12-18 | 2016-02-24 | 赵红 | 一种治疗甲状腺肿瘤的中药及其制备方法 |
CN105521295A (zh) * | 2015-12-28 | 2016-04-27 | 黄维清 | 一种治疗甲状腺肿瘤的中药配方 |
CN105521255A (zh) * | 2015-12-28 | 2016-04-27 | 黄维清 | 一种治疗甲状腺癌的中药配方 |
CN105561200A (zh) * | 2016-02-02 | 2016-05-11 | 耿冲 | 一种治疗甲状腺癌的中药配方及其制备方法 |
CN105749186A (zh) * | 2016-05-05 | 2016-07-13 | 毕恩旭 | 一种治疗甲状腺癌的中药制剂 |
CN105878880A (zh) * | 2016-05-23 | 2016-08-24 | 王激扬 | 一种治疗甲状腺癌的中药及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104474281A (zh) | 治疗甲状腺癌的中药配方 | |
CN104398831A (zh) | 一种治疗甲状腺癌的中药配方 | |
CN101829217B (zh) | 治疗慢性结肠炎的中药 | |
CN104524374A (zh) | 一种治疗肺癌的中药配方及其制备方法 | |
CN103316284B (zh) | 一种治疗胆结石的药物 | |
CN103341150B (zh) | 一种治疗慢性胃炎的中药制剂 | |
CN103977366A (zh) | 一种治疗慢性胆囊炎的药物 | |
CN103550696A (zh) | 一种治疗肺癌的药物 | |
CN103536881A (zh) | 一种治疗慢性胃炎的药物 | |
CN104225194A (zh) | 一种治疗失眠的中药 | |
CN104771579A (zh) | 一种治疗甲状腺肿瘤的中药配方 | |
CN102319352A (zh) | 一种治疗心脏病的中药配方 | |
CN104491447A (zh) | 一种治疗胃肠道肿瘤的复方药物 | |
CN103784796A (zh) | 一种治疗单纯性甲状腺肿的中药制剂 | |
CN101780220B (zh) | 一种治疗慢性胃炎的中药 | |
CN103908616B (zh) | 缓解肿瘤病人放疗反应的药剂及制备方法 | |
CN104352990A (zh) | 一种治疗甲状腺癌的药物组合物 | |
CN104474476A (zh) | 一种治疗甲状腺癌的中药配方及其冲剂的制备方法 | |
CN104383403A (zh) | 一种治疗慢性胃炎的中药组合物 | |
CN104352899A (zh) | 一种治疗慢性胃炎的中药制剂 | |
CN104043092A (zh) | 一种治疗胃酸过多的中药配方 | |
CN104258206A (zh) | 一种治疗急性肾小球肾炎的中药制剂 | |
CN103961586B (zh) | 一种治疗外阴炎的药物及制备方法 | |
CN104587251B (zh) | 一种治疗痛风的中药胶囊及其制备方法 | |
CN103623179B (zh) | 一种治疗打鼾的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150401 |
|
RJ01 | Rejection of invention patent application after publication |